Supplant

About:

Supplant is a biotechnology platform that makes sugar substitutes.

Top Investors: Khosla Ventures, Y Combinator, AgFunder, Coatue, Felicis

Description:

Supplant is a biotechnology platform working in the food sector. It develops natural food ingredients from agricultural resources to allow food manufacturers to decrease sugar, increase fiber, and boost the gut health-promoting qualities of its products.

Total Funding Amount:

$42.1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Cambridgeshire, United Kingdom

Founded Date:

2017-02-15

Contact Email:

supplant(AT)supplant.com

Founders:

Paul Dupree, Tom Simmons

Number of Employees:

11-50

Last Funding Date:

2021-10-12

IPO Status:

Private

Industries: